https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Remdesivir inhibited all investigated transporters at 10 µM and above. In conclusion, the low uptake rates suggest that OATP1B1 and its genetic variants, OATP1B3, OATP2B1 and OCT1 are not relevant for hepatocellular uptake of remdesivir in humans. Due to the rapid clearance of remdesivir, no clinically relevant transporter-mediated drug-drug interactions are expected.An abundance of literature has investigated the association between low back pain (LBP) and physical ability or function. It has been shown that LBP patients display redu
Like
Comment
Share
